Alvin S. Parven, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 22,659 shares at $133.95 ($3.1M) on 2017-01-05, disclosed to the SEC on 2017-01-09.
Seasonal sale ($3.1M) by Director — this insider has traded ALXN in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.65 | 853 | $114K | 3.6% |
| 2 | $133.95 | 15 | $2K | 0.1% |
| 3 | $133.95 | 185 | $25K | 0.8% |
| 4 | $135.69 | 31 | $4K | 0.1% |
| 5 | $135.70 | 369 | $50K | 1.6% |
| 6 | $137.56 | 7,375 |
| $1.0M |
| 32.4% |
| 7 | $137.56 | 599 | $82K | 2.6% |
| 8 | $138.60 | 421 | $58K | 1.9% |
| 9 | $138.60 | 5,176 | $717K | 22.9% |
| 10 | $139.49 | 5,350 | $746K | 23.8% |
| 11 | $139.49 | 435 | $61K | 1.9% |
| 12 | $140.59 | 1,433 | $201K | 6.4% |
| 13 | $140.59 | 117 | $16K | 0.5% |
| 14 | $141.22 | 22 | $3K | 0.1% |
| 15 | $141.23 | 278 | $39K | 1.3% |
| Total | $138.35 avg | 22,659 | $3.1M | 100% |
| Filing → |
| ALXN | SELL | 2015-11-04 | $160K | — | Filing → |
| ALXN | SELL | 2014-11-13 | $2.9M | — | Filing → |
| ALXN | SELL | 2014-05-15 | $2.0M | — | Filing → |